Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA
AN12855 is a novel cofactor-independent inhibitor of Mycobacterium tuberculosis InhA. AN12855 has potent activity against M. tuberculosis , good oral bioavailability, and comparable efficacy to isoniazid in infection models. New antitubercular agents are needed to combat the spread of multidrug- and...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Life Science Alliance LLC
2018-06-01
|
| Saila: | Life Science Alliance |
| Sarrera elektronikoa: | https://www.life-science-alliance.org/lookup/doi/10.26508/lsa.201800025 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
